Prevalence of combined atherosclerotic vascular lesions in patients with diabetes mellitus
https://doi.org/10.14341/2072-0351-5979
Abstract
During latest decade, as threat of acute complications of diabetes mellitus was surmounted, cardiovascular complications became leadingcause of death. Clinical manifestation of coronary, brachiocephalic and renal atherosclerosis is quite dramatic in diabetes mellitus,which determines extent of dissemination and intensity of lesions. Combination of these mutually confounding conditions is a characteristicproblem of patients with diabetes mellitus. Presence of 2+ risk factors (one of which is diabetes mellitus in itself) requiresactive examination in order to rule out coronary, brachiocephalic, peripheral and renal artery lesions. Aggressive care is necessaryin order to control progression of disease and administer adequate conservative and endovascular treatment with account of high riskof combination of lesions.
About the Authors
Svetlana Alexandrovna Gracheva
Endocrinology Research Centre, Moscow
Inna Igorevna Klefortova
Endocrinology Research Centre, Moscow
Minara Shamkhalovna Shamkhalova
Endocrinology Research Centre, Moscow
References
1. International Diabetes Federation, Diabetes Atlas, 5th ed. International Diabetes Federation; 2011.
2. Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral artery disease and aterotrombotic brain infarction in men and women <62 years of age. Am J Cardiol. 1994 Jul 1;74(1):64-65.
3. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA. 1979 May 11;241(19):2035-2038.
4. Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998 Jul 23;339(4):229-234.
5. Moss SE, Klein R, Klein BE. Cause-specific mortality in a population-based study of diabetes. Am J Public Health. 1991 Sep;81(9):1158-1162.
6. Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline Kinder L, Ellis D, Becker DJ. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes : 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2003 May;26(5):1374-1379.
7. Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, Manes C, Fuller JH; EURODIAB Prospective Complications Study Group. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care. 2004 Feb;27(2):530-537.
8. Olson JC, Edmundowicz D, Becker DJ, Kuller LH, Orchard TJ. Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes. 2000 Sep;49(9):1571-1578.
9. Anand DV, Lim E, Hopkins D, Corder R, Shaw LJ, Sharp P, Lipkin D, Lahiri A. Risk stratification in uncomplicated type 2 diabetes: Prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J. 2006 Mar;27(6):713-721. Epub 2006 Feb 23.
10. Scholte AJ, Schuijf JD, Kharagjitsingh AV, Jukema JW, Pundziute G, van der Wall EE, Bax JJ. Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart. 2008 Mar;94(3):290-295. Epub 2007 Jul 23.
11. ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults. 2011; p. 82.
12. Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, Garg S, Hamman RF, Rewers M; Coronary Artery Calcification in Type 1 Diabetes Study. Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes. 2003 Nov;52(11):2833-2839.
13. Cheng SV,Ting AC, Lau H,Wong J. Survival in patients with chronic lower extremity ischemia: a risk factor analysis. Ann Vasc Surg. 2000 Mar;14(2):158-165.
14. Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral Arterial Disease in Diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001 Aug;24(8):1433-1437.
15. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993 Feb;16(2):434-444.
16. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, Hermiller JB, Davidson CJ, Bashore TM. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992 May;2(11):1608-1616.
17. Weber-Mzell D, Kotanko P, Schumacher M, Klein W, Skrabal F. Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J. 2002 Nov;23(21):1684-1691.
18. Bonnici T, Goldsmith D. Renal and cardiac arterial disease: parallels and pitfalls. Br J Cardiol. 2008; 15(5): 261-265.
19. Cheung CM, Hegarty J, Kalra PA. Dilemmas in the management of renal artery stenosis. Br Med Bull. 2005 Sep 7;73-74:35- 55. Print 2005.
20. Шамхалова МШ, Клефортова ИИ., Шестакова МВ., Реми- зов ОВ., Бухман АИ, Алпенидзе ВА, Тугеева ЭФ, Шария МА, Устюжанин ДВ, Бузиашвили ЮИ, Дедов ИИ. Стеноз почечных артерий у больных сахарным диабетом 2 типа: клинические признаки, диагностика, прогностическая значимость. Тер. Архив. 2010;(6):15-19.
21. Reaven GM. Banting Lecture 1988. Role of Insulin in Human Disease. Diabetes. 1988 Dec;37(12):1595-1607.
22. Laakso M, Lehto S, Penttila I, Pyörälä K.. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation. 1993 Oct;88(4 Pt 1):1421-1430.
23. Taubert D, Rosenkranz A, Berkels R, Roesen R, Schömig E. Acute effects of glucose and insulin on vascular endothelium. Diabetologia. 2004 Dec;47(12):2059-2071. Epub 2004 Dec 15.
24. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study. BMJ. 1998 Mar 14;316(7134):823-828.
25. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS:35) prospective observational study. BMJ. 2000 Aug 12;321(7258):405-412.
26. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005 Dec 22;353(25):2643-2653.
27. Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 Diabetes and Coronary Artery Disease. Diabetes Care. 2006 Nov;29(11):2528-2538.
28. Schauer IE, Snell-Bergeon JK, Bergman BC, Maahs DM, Kretowski A, Eckel RH, Rewers M. Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes. 2011 Jan;60(1):306-314. Epub 2010 Oct 26.
29. Шестакова МВ. Дисфункция эндотелия - причина или следствие метаболического синдрома? РМЖ. 2001; 9(2):22.
30. Jansson J, Nilsson T, Johnsson O. Von Willebrand factor in plasma: a novel risk factor for fecurrent myocardial infarction and death. Br Heart J. 1991 Nov;66(5):351-355.
31. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective Study of Hemostatic Factors and Incidence of Coronary Heart Disease: the Atherosclerosis Risk in Communities (ARIC) Study. American Heart Association, Inc. 1997. (авторы и название то же, только есть ссылка на журнал в pubmed - Circulation. 1997 Aug 19;96(4):1102-1108.)
32. Hubbard AK, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med. 2000 May 1;28(9):1379-1386.
33. Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes. Diabetes Care. 2004 Mar;27(3):765-769.
34. Schulze F, Lenzen H, Hanefeld C, Bartling A, Osterziel KJ., Goudeva L, Schmidt-Lucke C, Kusus M, Maas R, Schwedhelm E, Strödter D, Simon BC, Mügge A, Daniel WG, Tillmanns H, Maisch B, Streichert T, Böger RH. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J. 2006 Sep;152(3):493.e1-8.
35. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol. 1993;11:767-804.
36. Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes: the Eurodiab Prospective Complications Study. Diabetologia. 2005 Feb;48(2):370-378. Epub 2005 Feb 4.
37. Soedamah-Muthu SS, Chaturvedi N, Teerlink T, Idzior-Walus B, Fuller JH, Stehouwer CD; the Eurodiab Prospective Complications Study Group. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study. J Intern Med. 2005 Nov;258(5):450-459.
38. Bosnyak Z, Forrest KYZ, Becker D, Orchard TJ; Pittsburgh Epidemology of Diabetes Complications Study. Do plasminogen activator inhibitor (PAI-1) or tissue plasminogen activator PAI-1 complexes predict complications in type 1 diabetes? Diabet Med. 2003 Feb;20(2):147-151.
39. Wadwa RP, Kinney GL, Ogden L, Snell-Bergeon JK, Maahs DM, Cornell E, Tracy RP, Rewers M. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. Int J Biochem Cell Biol. 2006;38(5-6):996-1003. Epub 2005 Oct 18.
40. Martín-Ventura JL, Blanco-Colio LM, Tuñón J, Muñoz-García B, Madrigal-Matute J, Moreno JA, Vega de Céniga M, Egido J. Biomarkers in Cardiovascular Medicine. Rev Esp Cardiol. 2009 Jun;62(6):677-688.
41. Matter CM, Handschin C. RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted), Inflammation, Obesity, and the Metabolic Syndrome. Circulation. 2007 Feb 27;115(8):946-948.
Review
For citations:
Gracheva S.A., Klefortova I.I., Shamkhalova M.Sh. Prevalence of combined atherosclerotic vascular lesions in patients with diabetes mellitus. Diabetes mellitus. 2012;15(1):49-55. (In Russ.) https://doi.org/10.14341/2072-0351-5979
Views:
1761
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
